- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- GAL- FUL: beta-L-fucopyranose-(1-2)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 5 x IMD: IMIDAZOLE(Non-covalent)
IMD.2: 5 residues within 4Å:- Chain A: R.80, G.81, S.160, T.161, W.162
1 PLIP interactions:1 interactions with chain A- Water bridges: A:S.160
IMD.3: 6 residues within 4Å:- Chain A: L.53, Q.54, G.55, T.57, V.102, L.106
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.57
IMD.4: 5 residues within 4Å:- Chain A: E.140, W.162, K.230
- Chain B: H.139
- Ligands: EDO.26
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:H.139, A:K.230
- pi-Stacking: A:W.162
IMD.15: 5 residues within 4Å:- Chain B: L.53, Q.54, G.55, T.57, L.106
No protein-ligand interaction detected (PLIP)IMD.16: 6 residues within 4Å:- Chain A: H.139
- Chain B: E.140, W.162, K.230
- Ligands: NAG-GAL-FUL.1, EDO.26
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:K.230, A:H.139
- pi-Stacking: B:W.162
- 21 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 8 residues within 4Å:- Chain A: L.60, T.62, G.63, A.66, R.68, L.91, K.174
- Chain B: P.26
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: G.16, P.26, I.27, D.28
- Chain B: L.60, N.92
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: Q.58, N.90, L.91, N.92, L.106
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: A.181, S.182, D.184, G.231, G.232
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: P.11, L.13, E.245, H.249
- Chain B: Q.248, Q.252
Ligand excluded by PLIPEDO.10: 3 residues within 4Å:- Chain A: K.6, Q.252, E.253
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: P.98, T.99, E.100, D.101, K.153, M.205, N.206
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: F.189, Q.191, R.224, P.236, A.237
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: P.24, P.61
- Chain B: P.24, P.61, T.62
Ligand excluded by PLIPEDO.14: 4 residues within 4Å:- Chain A: L.53, Q.58, L.59
- Chain B: E.17
Ligand excluded by PLIPEDO.17: 8 residues within 4Å:- Chain A: P.26
- Chain B: L.60, T.62, G.63, A.66, R.68, L.91, K.174
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain B: S.160, T.161, W.162
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain A: F.226, I.227, P.228
- Chain B: R.68, R.122
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain B: K.6, Q.252, E.253
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain B: Q.58, N.90, L.91, N.92, L.106
Ligand excluded by PLIPEDO.22: 5 residues within 4Å:- Chain B: K.153, T.202, L.203, M.205
- Ligands: EDO.23
Ligand excluded by PLIPEDO.23: 8 residues within 4Å:- Chain B: P.98, T.99, E.100, D.101, K.153, M.205, N.206
- Ligands: EDO.22
Ligand excluded by PLIPEDO.24: 5 residues within 4Å:- Chain B: F.189, Q.191, R.224, P.236, A.237
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain B: P.11, L.13, L.18, W.246, Y.303, F.304
Ligand excluded by PLIPEDO.26: 7 residues within 4Å:- Chain A: E.140, K.230
- Chain B: H.139, E.140, W.162
- Ligands: IMD.4, IMD.16
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain B: T.193, L.194, S.196, N.204
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hansman, G.S. et al., Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J.Virol. (2011)
- Release Date
- 2011-05-11
- Peptides
- Capsid protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- GAL- FUL: beta-L-fucopyranose-(1-2)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 5 x IMD: IMIDAZOLE(Non-covalent)
- 21 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hansman, G.S. et al., Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J.Virol. (2011)
- Release Date
- 2011-05-11
- Peptides
- Capsid protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B